The study of tumor regression mode, Ki67 expression and neoadjuvant chemotherapy on prognosis of different molecular breast cancer
Minerva Surg
.
2023 Dec 21.
doi: 10.23736/S2724-5691.23.10187-0.
Online ahead of print.
Authors
Xiangjuan Liu
1
,
Jun Zhao
2
,
Jian Li
1
,
Yuan Wang
1
,
Hongyan Zang
3
Affiliations
1
Department of Breast Surgery, Yantaishan Hospital, Yantai, China.
2
Department of Oncology, Yantai Penglai People's Hospital, Yantai, China.
3
Department of Breast Surgery, Yantaishan Hospital, Yantai, China - 2420082988@qq.com.
PMID:
38127438
DOI:
10.23736/S2724-5691.23.10187-0
No abstract available